Home » BGI Offer for Complete Genomics Extended Until March 1

BGI Offer for Complete Genomics Extended Until March 1

Feb 25, 2013
|
staff reporter

NEW YORK (GenomeWeb News) – BGI said after the close of the market on Friday it has again extended its cash tender offer for Complete Genomics.

The $118 million deal is now set to expire at midnight ET on March 1. The offer has been pushed back several times and most recently was to expire at midnight Feb. 22.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

What's Popular?

In Clinical Sequencing

  1. NIH All of Us Program Awards $28.6M to Three Genome Centers Led by Baylor, Broad, UW

  2. New Data Underscores Volatility of Variant Classification, Highlights Need for Regular Reanalysis

  3. Nanopore Sequencing Becomes More Portable to Enable Outbreak Surveillance in Field

    Premium

  4. Geisinger Exome Study IDs Breast Cancer Risk Variants That May Not Have Been Detected in Routine Care

  5. GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.